About this trial
The goal of this clinical trial is to find out if giving certain medications once a day works just as well as giving them twice a day to treat infections around the lungs (called pleural infections). These medications-tissue plasminogen activator (tPA) and deoxyribonuclease (DNase)-are placed through a chest tube into the space between the lung and the chest wall to help clear out the infection.
The investigators are trying to learn:
* Does using the medicine once a day work just as well as using it twice a day? * Are there any differences in outcomes between patients who get the medicine once a day versus twice a day? * Does more or less fluid remain in the chest (seen on a chest x-ray) depending on how often the medicine is given?
Participants will:
* Have an infection around their lung and will already be getting normal hospital care, including a chest tube to drain the infected fluid around their lung. * Be asked to give permission to join the study. * Be randomly chosen (like flipping a coin) to get the medications either once a day or twice a day through the chest tube.
Eligibility criteria
Qualifiers
Written informed consent obtained from patient or patient's legally authorized representative (LAR) to participate in the study and HIPAA authorization for release of personal health information.
Subject is willing and able to comply with study procedures based on the judgement of the investigator or protocol designee.
Age ≥ 18 years at the time of consent.
Patient is admitted to the hospital and with a pleural effusion that is drained with a small-bore chest tube or one that allows for administration of IET
Disqualifiers
Known pregnancy or lactating females
Prisoners
Age <18 years at time of consent
Previous treatment with intra-pleural fibrinolytic agents, DNase, or both during the same hospital admission
Trial design
Treatments tested in this trial
- Fibrinolytic once daily
- Fibrinolytic twice daily
- DNA degradation once daily
- DNA degradation twice daily
Treatment groups
Sponsors and collaborators
University of North Carolina, Chapel Hill
Lead sponsor
Northwestern Memorial Hospital
Collaborator
Henry Ford Health System
Collaborator
Yale University
Collaborator
Rush University Medical Center
Collaborator
Dartmouth-Hitchcock Medical Center
Collaborator